Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan
· Delayed Price · Currency is TWD 48.60
-3.20 (-6.18%)
Mar 9, 2026, 1:30 PM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 4.33 billion as of March 9, 2026. Its market cap has increased by 9.95% in one year.
Market Cap
4.33B
Enterprise Value
3.53B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.60
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 4.33B, a decrease of -36.36%. That is a compound annual growth rate of -3.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 4.15B |
| BioGend Therapeutics | 4.53B |
| Energenesis Biomedical CO.,LTD. | 3.99B |
| Formosa Pharmaceuticals | 3.87B |
| ACRO Biomedical | 3.80B |
| OBI Pharma | 4.98B |
| Locus Cell | 5.06B |
| Genovate Biotechnology | 3.70B |